Effect of folinic acid on serum homocysteine, TNFα, IL-10, and HMGB1 gene expression in head injury model
Open Access
- 6 April 2021
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 65, 102273
Abstract
Background: Head injury or traumatic brain injury is the leading cause of mortality and morbidity. Many modalities of neuroprotection had been developed in brain injury but there was no much information regarding folinic acid's effect on neuroinflammation associated with homocysteine, TNFα, IL-10, and HMGB1. Objective: This study aimed to investigate whether folinic acid has improving effect on head injury model. Method: This study was done in the rat's head injury model using modified Marmarou weight drop model. Fifteen rats were randomized and grouped into 3 groups: Group A: Folinic acid (+), head injury (−); Group B: Folinic acid (−), head injury (+); Group C: Folinic acid (+), head injury (+). Folinic acid was administered intraperitoneally with a dose of 60 mg/m2. Blood samples were taken immediately after head injury (H0), 12 h (H12), and 24 h (H24) after head injury from the lateral vein of tail. Serum level of homocysteine, TNFα, and IL-10 were measured using ELISA, and HMGB1 gene expression was measured with Real-Time RT-PCR. Results: This study found serum level of homocysteine, TNFα, IL-10 and HMGB1 gene expression were markedly increased at all time points after head injury. Significantly lower level of serum homocysteine, TNFα, IL-10 and HMGB1 gene expression were found after 24 h treatment with folinic acid in group C compared to those in group B. Conclusion: Folinic acid may have anti-inflammatory properties in traumatic brain injury by inhibition of serum level of homocysteine, TNFα, IL-10 and HMGB1 gene expression.Keywords
This publication has 28 references indexed in Scilit:
- Traumatic Brain Injury Alters Methionine Metabolism: Implications for PathophysiologyFrontiers in Systems Neuroscience, 2016
- TNF biology, pathogenic mechanisms and emerging therapeutic strategiesNature Reviews Rheumatology, 2015
- Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapyCytokine, 2015
- Anti–high mobility group box‐1 antibody therapy for traumatic brain injuryAnnals of Neurology, 2012
- A simple procedure for estimation of total body surface area and determination of a new value of Meeh's constant in ratsLaboratory Animals, 2012
- Blood–brain barrier breakdown as a therapeutic target in traumatic brain injuryNature Reviews Neurology, 2010
- Early release of high mobility group box nuclear protein 1 after severe trauma in humans: role of injury severity and tissue hypoperfusionCritical Care, 2009
- Moderate and severe traumatic brain injury in adultsThe Lancet Neurology, 2008
- Pathophysiology of traumatic brain injuryBritish Journal of Anaesthesia, 2007
- The Effect of Traumatic Brain Injury Upon the Concentration and Expression of Interleukin-1?? and Interleukin-10 in the Rat2006